5 min read
Key Points
An experimental vaccine could lower the risk of melanoma coming back after treatment.
The deadly form of cancer has a high recurrence rate.
Doctors say the technology may be used in the future to prevent other forms of cancer.
An experimental new vaccine that could help prevent the deadly skin cancer melanoma from coming back after treatment is getting lots of attention: Developers Moderna and Merck shared in a joint press release that phase 3 results for their mRNA-based vaccine called intismeran “met endpoints of recurrence-free survival,” though they did not provide exact numbers.
The phase 3 trial builds on results from a…
Read the full article at PREVENTION.COM
